Abstract:Objective: To summarize the clinical manifestation and genetic characteristics of Chinese patients with achondroplasia (ACH) which is caused by pathogenic variants fibroblast growth factor receptor 3 (FGFR3) gene and establish the reference value of height centiles and height for age growth curve of patients for a more practical, simple and useful growth evaluation tool in China. Methods: Through a nationwide cross-sectional survey in China from July 2019 to January 2020 designed by Department of Pediatric Endocrinology and Genetics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 210 subjects (110 boys, 100 girls), who harbored the pathogenic variant of FGFR3 gene and were diagnosed with achondroplasia, were recruited. The clinical and genetic data of enrolled subjects were collected and analyzed to explore the clinical genetic characteristics of Chinese ACH patients. Furthermore, according to the data of height (body length under 2 years old) of boy and girl subjects aged 0-12 years, centiles and height for age growth curve of achondroplasia were calculated and established by LMS method respectively. Results: The characteristic clinical manifestations of 210 Chinese patients (0-14 years old) were disproportionate short stature (206/210, 98.1%), macrocephaly and characteristic facial features (205/210, 97.6%), trident configuration of the hands (191/210, 90.9%), limbs deformity (156/210, 74.3%), together with normal intelligence. Up to 81.9% (172/210) of patients have different complications, and the kyphosis (121/210, 57.6%) and narrow thoracic (79/210, 37.6%) are common complications. Besides, up to 98.6% (207/210) of patients harbored hotspot variants of FGFR3 gene which cause G380R amino acid substitutions. It is notable that the growth pattern of boy and girl patients (0-12 years old) is obviously different from the normal children (t=9.849, 9.596, P<0.01) respectively. The height different between ACH patients and normal children gradually widened with age. The average height of the boy (49.2 cm) and girl patients(48.4 cm) of achondroplasia at birth was -1.22 s and -2 s, however, at the age of twelve, the average height of the boy(113.7 cm) and girl patients(112.4 cm) of achondroplasia was -5.23 s and -6.15 s compared to currently standard reference height for age growth curve of normal children in China, respectively. Conclusions: The results of our study demonstrated that in China disproportionate short stature, macrocephaly and characteristic facial features were typical manifestations of ACH patients, and that up to 98.6% of patients harbored hotspot variants of FGFR3 gene. In addition, the reference value of height centiles and height for age growth curve of ACH patients we establish will be a valuable tool for evaluating the growth pattern, monitoring factors affecting growth, estimating ultimate height, and assessing the curative effect of growth-promoting treatments in Chinese patients with achondroplasia.

Familial Short Stature Caused by ACAN Gene Mutation:A Familial Case Report

Novel Pathogenic ACAN Variants in Non-Syndromic Short Stature Patients.

A High Proportion of Novel <i>ACAN</i> Mutations and Their Prevalence in a Large Cohort of Chinese Short Stature Children

Case analysis and literature review of 3 children with short stature with ACAN gene mutation

Genotype and phenotype in patients with ACAN gene variants: Three cases and literature review

Novel aggrecan variant, p. Gln2364Pro, causes severe familial nonsyndromic adult short stature and poor growth hormone response in Chinese children.

Growth-Promoting Therapies May Be Useful in Short Stature Patients with Nonspecific Skeletal Abnormalities Caused by Acan Heterozygous Mutations: Six Chinese Cases and Literature Review

A rare ACAN non-canonical splicing-site intron variant results in familial short stature

Genetic studies of 77 cases of short stature with unknown etiology

High frequency of pathogenic ACAN variants including an intragenic deletion in selected individuals with short stature

ACAN Gene Mutations in Short Children Born SGA and Response to Growth Hormone Treatment

Clinical Characteristics of Pathogenic ACAN Variants and 3-Year Response to Growth Hormone Treatment: Real-World Data

A rare case of skeletal dysplasia: biallelic variant in ACAN gene

Short Stature in Klinefelter Syndrome From Aggrecan Mutation

FGD1 Variant Associated with Aarskog–Scott Syndrome

Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family

Different AHO Phenotype in a Chinese Family with a Novel GNAS Missense Variant: a Case Report.

[Exploring the Clinical Genetic Characteristics and Height for Age Growth Curve of 210 Patients with Achondroplasia in China].

Clinical and Gene Analysis among One Family Members of Congenital Adrenal Hyperplasia

Dual Diagnosis of Osteogenesis Imperfecta (OI) and Short Stature and Advanced Bone Age with or Without Early-Onset Osteoarthritis And/or Osteochondritis Dissecans (SSOAOD) Reveals a Cumulative Effect on Stature Caused by Mutations in COL1A1 and ACAN Genes.

Ser217cys Mutation in the Ig Ii Domain of Fgfr3 in A Chinese Family with Autosomal Dominant Achondroplasia